Apo-Amoxi Interactions
There are 58 drugs known to interact with Apo-Amoxi (amoxicillin), along with 6 disease interactions. Of the total drug interactions, 7 are major, 44 are moderate, and 7 are minor.
- View all 58 medications that may interact with Apo-Amoxi
- View Apo-Amoxi disease interactions (6)
Most frequently checked interactions
View interaction reports for Apo-Amoxi (amoxicillin) and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Adderall (amphetamine / dextroamphetamine)
- Admelog (insulin lispro)
- Aerius (desloratadine)
- Alesse-28 (ethinyl estradiol / levonorgestrel)
- cephalexin
- cetirizine
- ciprofloxacin
- citalopram
- clonazepam
- dexamethasone
- diclofenac
- escitalopram
- gabapentin
- ibuprofen
- melatonin
- mirtazapine
- modafinil
- naproxen
- Nasonex (mometasone nasal)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- pantoprazole
- prednisone
- Synthroid (levothyroxine)
- TobraDex (dexamethasone / tobramycin ophthalmic)
- trazodone
- turmeric
- Tylenol (acetaminophen)
- venlafaxine
- Vitamin D3 (cholecalciferol)
Apo-Amoxi disease interactions
There are 6 disease interactions with Apo-Amoxi (amoxicillin) which include:
Report options
QR code containing a link to this page
More about Apo-Amoxi (amoxicillin)
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: aminopenicillins
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.